0001225208-24-001485.txt : 20240202
0001225208-24-001485.hdr.sgml : 20240202
20240202160942
ACCESSION NUMBER: 0001225208-24-001485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tsourapas Panagiotis
CENTRAL INDEX KEY: 0001576945
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00644
FILM NUMBER: 24591465
MAIL ADDRESS:
STREET 1: C/O COLGATE-PALMOLIVE COMPANY
STREET 2: 300 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO
CENTRAL INDEX KEY: 0000021665
STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 131815595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 2123102000
MAIL ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
X0508
4
2024-01-31
0000021665
COLGATE PALMOLIVE CO
CL
0001576945
Tsourapas Panagiotis
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK
NY
10022
1
Grp Pres, Eur& Developing Mkts
0
Common Stock
2024-01-31
4
M
0
30433.0000
68.1600
A
42559.0000
D
Common Stock
2024-01-31
4
S
0
30433.0000
84.4053
D
12126.0000
D
Common Stock
4218.0000
I
By Issuer's 401(k) Plan Trustee
Common Stock
837.0000
I
By Spouse
Common Stock
59282.0000
I
By Trust
Stock Option (Right to Buy)
68.1600
2024-01-31
4
M
0
30433.0000
0.0000
D
2024-09-13
Common Stock
30433.0000
0.0000
D
Exercise of stock options awarded under the issuer's incentive compensation plan.
Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $84.31 to $84.495, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2018 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact
2024-02-02